Social license for the use of big data in the COVID-19 era
Strategies to enable the reopening of businesses and schools in countries emerging from social-distancing measures revolve around knowledge of who has COVID-19 or is displaying recognized symptoms, the people with whom they have had physical contact, and which groups are most likely to experience ad...
Guardado en:
Autores principales: | James A. Shaw, Nayha Sethi, Christine K. Cassel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c676e5eab02547fc8c30592f760ed1c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
por: Sara Gerke, et al.
Publicado: (2020) -
Medical records-based chronic kidney disease phenotype for clinical care and “big data” observational and genetic studies
por: Ning Shang, et al.
Publicado: (2021) -
A reporting and analysis framework for structured evaluation of COVID-19 clinical and imaging data
por: Gabriel Alexander Salg, et al.
Publicado: (2021) -
Measuring the effect of Non-Pharmaceutical Interventions (NPIs) on mobility during the COVID-19 pandemic using global mobility data
por: Berber T. Snoeijer, et al.
Publicado: (2021) -
Interaction of Diet/Lifestyle Intervention and TCF7L2 Genotype on Glycemic Control and Adiposity among Overweight or Obese Adults: Big Data from Seven Randomized Controlled Trials Worldwide
por: Tao Huang, et al.
Publicado: (2021)